Envoy Medical, Inc. (NASDAQ: COCH) reported Q2 EPS of ($0.07), $0.01 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $50 thousand versus the consensus estimate of $100 thousand.

For earnings history and earnings-related data on Envoy Medical, Inc. (COCH) click here.